These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8537093)

  • 1. Autoreactive T-cell line derived from PBMC of a rhesus macaque immunized with inactivated SIV vaccine.
    Teng XC; Ashworth LA
    Immunol Lett; 1995; 47(1-2):145-6. PubMed ID: 8537093
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines.
    de Vries P; Heeney JL; Boes J; Dings ME; Hulskotte EG; Dubbes R; Koornstra W; ten Haaft P; Akerblom L; Eriksson S
    Vaccine; 1994 Nov; 12(15):1443-52. PubMed ID: 7887023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques.
    Coutsinos Z; Villefroy P; Gras-Masse H; Guillet JG; Bourgault-Villada I
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):357-66. PubMed ID: 15708309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3).
    Shankar P; Schlom J; Hodge JW
    Vaccine; 2001 Dec; 20(5-6):744-55. PubMed ID: 11738738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine.
    Cranage MP; McBride BW; Rud EW
    Vaccine; 1995 Jul; 13(10):895-900. PubMed ID: 7483761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell vaccination could reduce SIV viral load in semen of rhesus monkeys.
    Immunotherapy; 2010 Jan; 2(1):6. PubMed ID: 20635885
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity of a DNA prime and recombinant adenovirus boost regime significantly varies between rhesus macaques of Chinese and Indian origins.
    Stahl-Hennig C; Suh YS; Park KS; Sauermann U; Kim KS; Ahn S; Franz M; Schulte R; Stolte-Leeb N; Hunsmann G; Sung YC
    J Med Primatol; 2007 Aug; 36(4-5):195-205. PubMed ID: 17669208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo.
    Luke W; Coulibaly C; Dittmer U; Voss G; Oesterle R; Makoschey B; Sauermann U; Jurkiewicz E; Stahl-Henning C; Petry H; Hunsmann G
    Virology; 1996 Feb; 216(2):444-50. PubMed ID: 8607276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine development using the simian immunodeficiency virus model for AIDS.
    Norley S; Beer B; Binninger-Schinzel D; Vogel T; Hohn O; Seibold E; Radke D; Cosma C; Kurth R
    Intervirology; 2002; 45(4-6):267-74. PubMed ID: 12566709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.
    Lifson JD; Rossio JL; Piatak M; Bess J; Chertova E; Schneider DK; Coalter VJ; Poore B; Kiser RF; Imming RJ; Scarzello AJ; Henderson LE; Alvord WG; Hirsch VM; Benveniste RE; Arthur LO
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):772-87. PubMed ID: 15307924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation.
    Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
    Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
    Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The thymus gland of rhesus macaque in SIV vaccination/infection].
    Baroni CD; Pescarmona E; Sebastiani S; Uguccioni M
    Pathologica; 2003 Oct; 95(5):230. PubMed ID: 14988981
    [No Abstract]   [Full Text] [Related]  

  • 18. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
    Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.